Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
2014 · Nature Medicine · 820 citations
https://doi.org/10.1038/nm.3545
M
Michael A. Laflamme
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
126
Papers
15.8K
Citations
43
h-index
71
i10-index
Michael A. Laflamme is an academic researcher from University Health Network. The author has contributed to research in topics: Pluripotent Stem Cells Research & Tissue Engineering and Regenerative Medicine & Congenital heart defects research. The author has an h-index of 43, co-authored 108 publications.
ORCID: 0000-0001-5908-880XPapers by this author
worksGeneration of mature compact ventricular cardiomyocytes from human pluripotent stem cells
2021 · Nature Communications · 157 citations
https://doi.org/10.1038/s41467-021-23329-z
Modeling human multi-lineage heart field development with pluripotent stem cells
2022 · Cell stem cell · 92 citations
https://doi.org/10.1016/j.stem.2022.08.007
Optical mapping of human embryonic stem cell-derived cardiomyocyte graft electrical activity in injured hearts
2020 · Stem Cell Research & Therapy · 21 citations
https://doi.org/10.1186/s13287-020-01919-w
The role of regenerative therapy in the treatment of right ventricular failure: a literature review
2020 · Stem Cell Research & Therapy · 11 citations
https://doi.org/10.1186/s13287-020-02022-w
Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes
2024 · Nature Communications · 8 citations
https://doi.org/10.1038/s41467-024-54337-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat